Pharmacovigilance Market 2018 : Global Industry Trends and Analysis Report - PowerPoint PPT Presentation

About This Presentation
Title:

Pharmacovigilance Market 2018 : Global Industry Trends and Analysis Report

Description:

New Market Research Reports Title Pharmacovigilance Market" Has Been Added to Adroit Market Research into reports database. – PowerPoint PPT presentation

Number of Views:82

less

Transcript and Presenter's Notes

Title: Pharmacovigilance Market 2018 : Global Industry Trends and Analysis Report


1
Global Pharmacovigilance Market
  • Drivers, Restraints, Potential Growth
    Opportunities, Product Size, Application
    Estimation, Vendor Competitive Landscape, Trends
    and Forecast 2018-2025

Single Use License US 5200
Request Sample
2
Global Pharmacovigilance Market Size, Share ,
Forecast Report 2025
  • The Global Pharmacovigilance Market Share is
    being driven by escalated awareness in the public
    health sector along with rise in preference for
    safe medicines. Number of national
    pharmacovigilance centers is increasing which is
    playing an imperative role in aiding the market.
    Besides that, pharmacovigilance is experiencing
    various challenges to develop improved healthcare
    system. The factor that restrain the market
    growth is unavailability of unskilled labor and
    data about drugs collected via the web. However,
    rigorous pharmacovigilance activities, if
    mandated may expand global Pharmacovigilance
    market size, encouraging it touch up to USD xx.xx
    Billion by the end of 2025. The growth rate was
    steady in 2018, growing with an optimistic CAGR
    of x.x during the forecast period.
  • Based on regional segmentation, North America
    ranks highest in the global pharmacovigilance
    market because of high regulatory compliance and
    incidences of adverse drug reactions for
    pharmacovigilance. In addition to that, abundant
    biotechnology and pharmaceutical companies, is
    propelling regional market growth. Asia-Pacific
    considered fastest growing region of global
    pharmacovigilance market as there are higher
    incidences of adverse drug reactions, rising
    concern for efficacy and drug safety, and
    toxicity, and growing number of biotechnology and
    pharmaceuticals companies. Moreover, the
    pharmacovigilance market is rapidly growing
    because of high growth of generic drugs market in
    emerging economies like India and China.
  • The global Pharmacovigilance industry is
    segmented on the basis of methods, clinical trial
    phase, applications, end-user, region and service
    providers. Based on different phases of clinical
    trial, the market has several categories which
    include phase I clinical trial, phase II clinical
    trial, phase III clinical trial, and phase IV
    clinical trial. The leading segment is phase IV
    clinical trial segment, carrying largest global
    Pharmacovigilance market share of 75.2 in 2017.

3
Global Pharmacovigilance Market Size, Share ,
Forecast Report 2025
  • Pharmacovigilance is essential as safety
    surveillance post drug is sold to patients. It
    finds and reports ADRs and damaging effects when
    drugs are discontinued or restricted in use.
    Phase IV pharmacovigilance may impact badly on
    business or companys financial performance.
    Therefore, growing number of pharmaceutical
    companies and higher number of medicines favor
    the market growth. Preclinical trial will have
    positive growth due to accelerating number of
    novel drug developments by biotech and pharma
    companies across the world. Preclinical trial are
    essential part of drug development and drug
    assessment. Thus, growing demand for targeted
    therapies owe to higher number of diseases.
  • On the basis of pharmacovigilance methods, the
    global Pharmacovigilance industry is classified
    as targeted spontaneous reporting, spontaneous
    reporting, electronic health record mining,
    intensified adverse drug reaction reporting and
    cohort event monitoring. In terms of service
    providers, the global pharmacovigilance market is
    bifurcated into contract outsourcing
    pharmacovigilance and in-house pharmacovigilance.
    Leading segment is contract outsourcing
    pharmacovigilance and is anticipated to grow at a
    higher rate in the next couple of years.
  • Some of the main players operating in the global
    Pharmacovigilance market include Sanofi,
    Accenture, Cognizant Technology Solutions,
    Clinquest Group B.V., Wipro Limited, ICON plc,
    PAREXEL International Corporation, F. Hoffmann-La
    Roche Ltd., Novartis AG, iGATE Corporation,
    Pfizer Inc., Bristol-Myers Squibb Company and
    GlaxoSmithKline.
  • Browse the complete report on _at_
    https//www.adroitmarketresearch.com/industry-repo
    rts/pharmacovigilance-market

4
Key segments of Global Pharmacovigilance Market
  • Based on end-use, the market has been segmented
    into,
  • Pharmaceutical
  • Medical Device
  • Biotechnological
  • Based on type of method, the market has been
    segmented into,
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining
  • Intensified ADR Reporting
  • Spontaneous Reporting
  • Based on region, the market has been segmented
    into,
  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

5
Global Pharmacovigilance Market Size, Share ,
Forecast Report 2025
  • What to expect from the upcoming report on
    Global Pharmacovigilance Market
  • - Future prospects and current trends of the
    global pharmacovigilance market by the end of
    forecast period (2018-2025)
  • - Information regarding technological
    progressions as well as innovations taking place
    in developing economies
  • - Supportive initiatives by government likely to
    influence the market dynamics
  • - Trends, drivers, opportunities, restraints,
    challenges and key developments in the market
  • - In-depth analysis of different market
    segmentations including regional segmentations,
    and product types
  • - Deep analysis about the competitive landscape
    of the market and the initiatives by them to
    improve this market
  • Who should buy this report?
  • Venture capitalists, Investors, financial
    institutions, Analysts, Government organizations,
    regulatory authorities, policymakers,
    researchers, strategy managers, and academic
    institutions looking for insights into the market
    to determine future strategies.
  • Purchase a single user copy of the global
    Pharmacovigilance market report_at_
    https//www.adroitmarketresearch.com/researchrepor
    t/purchase/687

6
About Us
  • Adroit Market Research is an India-based business
    analytics and consulting company. Our target
    audience is a wide range of corporations,
    manufacturing companies, product/technology
    development institutions and industry
    associations that require understanding of a
    markets size, key trends, participants and
    future outlook of an industry. We intend to
    become our clients knowledge partner and provide
    them with valuable market insights to help create
    opportunities that increase their revenues. We
    follow a code Explore, Learn and Transform. At
    our core, we are curious people who love to
    identify and understand industry patterns, create
    an insightful study around our findings and churn
    out money-making roadmaps. Our analysts have
    tracked high growth markets in chemicals
    materials, healthcare pharmaceuticals,
    semiconductor electronics, energy power, food
    retail, consumer goods, technology, and
    machinery equipment sectors across the world to
    identify new opportunities, potential customers,
    prepare go-to-market (GTM) strategies, identify
    segments for revenue growth for companies, and
    many more.
  • US Headquarters3131 McKinney Ave Ste 600
    Dallas, TX 75204 ,U.S.A 
  • Phone 1 (214) 884-6068
  • Email sales_at_adroitmarketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com